The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Glucose variability is associated with intensive care unit mortality*
Abstract
OBJECTIVE: Mounting evidence suggests a role for glucose variability in predicting intensive care unit (ICU) mortality. We investigated the association between glucose variability and intensive care unit and in-hospital deaths across several ranges of mean glucose. DESIGN: Retrospective cohort study. SETTING: An 18-bed medical/surgical ICU in a teaching hospital. PATIENTS: All patients admitted to the ICU from January 2004 through December 2007. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Two measures of variability, mean absolute glucose change per hour and sd, were calculated as measures of glucose variability from 5728 patients and were related to ICU and in-hospital death using logistic regression analysis. Mortality rates and adjusted odds ratios for ICU death per mean absolute glucose change per hour quartile across quartiles of mean glucose were calculated. Patients were treated with a computerized insulin algorithm (target glucose 72-126 mg/dL). Mean age was 65 +/- 13 yrs, 34% were female, and 6.3% of patients died in the ICU. The odds ratios for ICU death were higher for quartiles of mean absolute glucose change per hour compared with quartiles of mean glucose or sd. The highest odds ratio for ICU death was found in patients with the highest mean absolute glucose change per hour in the upper glucose quartile: odds ratio 12.4 (95% confidence interval, 3.2-47.9; p < .001). Mortality rates were lowest in the lowest mean absolute glucose change per hour quartiles. CONCLUSIONS: High glucose variability is firmly associated with ICU and in-hospital death. High glucose variability combined with high mean glucose values is associated with highest ICU mortality. In patients treated with strict glycemic control, low glucose variability seemed protective, even when mean glucose levels remained elevated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“GV was not reported as an outcome measure in the Leuven studies, the GluControl study, the Volume Substitution and Insulin Therapy in Severe Sepsis study, and the Normoglycemia in Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation study (1, 2, 4, 7, 8).”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862
Van den Berghe, G., Wouters, P. J., Bouillon, R., Weekers, F., Verwaest, C., Schetz, M., Vlasselaers, D., Ferdinande, P., & Lauwers, P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000045568.12881.10 · Cited by 1,455
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310 · cited 1×
“In rats, glycemic reperfusion after hypoglycemia caused neuronal death (25), and altering glucose levels were impairing endothelial function in healthy volunteers (26).”
Background
Research works printed but not linked: 1
- DeFronzo, 1979, Am J Physiol, 237, E214
Cited by
ESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit
Singer, P., Blaser, A. R., Berger, M. M., Calder, P. C., Casaer, M., Hiesmayr, M., Mayer, K., Montejo-Gonzalez, J. C., Pichard, C., Preiser, J.-C., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.07.011 · Cited by 793
Krinsley, J. S., Egi, M., Kiss, A., Devendra, A. N., Schuetz, P., Maurer, P. M., Schultz, M. J., van Hooijdonk, R. T., Kiyoshi, M., Mackenzie, I. M., et al. (2013) · Critical Care · doi:10.1186/cc12547 · Cited by 369
Hill, N. R., Oliver, N. S., Choudhary, P., Levy, J. C., Hindmarsh, P., & Matthews, D. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0247 · Cited by 362
Metrics for glycaemic control - from HbA1c to continuous glucose monitoring
Kovatchev, B. P. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.3 · Cited by 272
Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes
Kovatchev, B., & Cobelli, C. (2016) · Diabetes Care · doi:10.2337/dc15-2035 · Cited by 255
Glucose Variability: A Review of Clinical Applications and Research Developments
Rodbard, D. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0092 · Cited by 154
“16–”
Association between intensive care unit-acquired dysglycemia and in-hospital mortality.
Badawi, O., Waite, M. D., Fuhrman, S. A., & Zuckerman, I. H. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182656ae5 · Cited by 142
Qu, Y., Jacober, S. J., Zhang, Q., Wolka, L. L., & DeVries, J. H. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0099 · Cited by 126
Self-citationMesejo, A., Montejo-González, J. C., Vaquerizo-Alonso, C., Lobo-Tamer, G., Zabarte-Martinez, M., Herrero-Meseguer, J. I., Acosta-Escribano, J., Blesa-Malpica, A., & Martinez-Lozano, F. (2015) · Critical Care · doi:10.1186/s13054-015-1108-1 · Cited by 94
Tumminia, A., Crimi, S., Sciacca, L., Buscema, M., Frittitta, L., Squatrito, S., Vigneri, R., & Tomaselli, L. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2557 · Cited by 100
Siegelaar, S. E., Kerr, L., Jacober, S. J., & Devries, J. H. (2011) · Diabetes Care · doi:10.2337/dc10-1684 · Cited by 89
Self-citationSiegelaar, S. E., Hermanides, J., Oudemans-van Straaten, H. M., van der Voort, P. H., Bosman, R. J., Zandstra, D. F., & DeVries, J. H. (2010) · Critical Care · doi:10.1186/cc9369 · Cited by 82
Self-citationMellbin, L. G., Malmberg, K., Rydén, L., Wedel, H., Vestberg, D., & Lind, M. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs384 · Cited by 57
Saur, N. M., Kongable, G. L., Holewinski, S., O’Brien, K., & Nasraway, S. A. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.07.003 · Cited by 37
Kovatchev, B., Umpierrez, G., DiGenio, A., Zhou, R., & Inzucchi, S. E. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815587014 · Cited by 18
Cichosz, S. L., & Hejlesen, O. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211015206 · Cited by 15
Transition from intravenous to subcutaneous insulin in critically ill adults
Doolin, M. K., Walroth, T. A., Harris, S. A., Whitten, J. A., & Fritschle-Hilliard, A. C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816629985 · Cited by 13
“Glucose variability has been independently associated with short-term ICU mortality.(14-16) The mechanism of harm includes oxidative stress, neuronal damage, mitochondrial damage, and coagulation activation.”
BackgroundInfluentialMader, J. K., Motschnig, M., Theiler-Schwetz, V., Eibel-Reisz, K., Reisinger, A. C., Lackner, B., Augustin, T., Eller, P., & Mirth, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0082 · Cited by 4
Metadata
- Authors
- Hermanides, J., Vriesendorp, T. M., Bosman, R. J., Zandstra, D. F., Hoekstra, J. B., & DeVries, J. H.
- Venue
- Critical Care Medicine
- Published
- 2010-03
- Volume
- 38
- Issue
- 3
- Pages
- 838-842
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2124719214
- Cited by
- 437
- References
- 38
- FWCI
- 28.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.